Drug Discovery World

JULY 25, 2023

Alnylam Pharmaceuticals has revealed results from its Phase I study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension. The results are published in the New England Journal of Medicine (NEJM). The key data showed that compared to placebo, zilebesiran was associated with dose-dependent reductions in serum AGT, achieving tonic blood pressure control with consistent and durable blood pressure reduction

Clinical Development 242

Clinical Development Pharmaceuticals Hospitals Treatment 242

Drug Target Review

JULY 4, 2023

Over the last two decades, an increasing number of Antibody Drug Conjugate (ADC) therapeutics have been approved for oncology indications. These therapies have broadened treatment options for patients to expand beyond the more traditional small molecule drug alternatives. Through their unique modes of action, ADCs have been heralded as having the potential to positively impact not only cancer patient outcomes but also quality of life, an increasingly important factor in treatment decisions for t

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

BioPharma Drive: Drug Pricing

JULY 6, 2023

Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.

Therapies 134

Therapies Treatment 134

Drugs.com

JULY 5, 2023

WEDNESDAY, July 5, 2023 -- A new blood test approved by the U.S. Food and Drug Administration can predict imminent preeclampsia, helping pregnant women who are at risk for this severe and sometimes deadly form of high blood pressure. The test can.

FDA Approval 134

FDA Approval FDA Drugs 134

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Perficient: Drug Development

JULY 5, 2023

Insite is now Configured Commerce. In this blog, we will learn below points: Replacing an existing page in Spire Example of replacing an existing page Implementation in Local machine Replacing an existing widget in Spire Example of replacing an existing widget Implementation in Local machine In this blog post, we will explore the process of replacing existing pages and widgets in Spire, a popular content management system.

105

105

ProRelix Research

JULY 6, 2023

Biosimilar clinical trials and study designs’ Considerations The rising prevalence and large market share of biological products emphasize their importance as treatment options for several cancers and autoimmune diseases. In […] The post Biosimilar clinical trials and study designs’ considerations appeared first on ProRelix Research.

Biosimilars 105

Biosimilars Clinical Trials Trials Production 105

Drug Target Review

JULY 5, 2023

What is a microscopy tech centre and how do they assist drug discovery research? We work in a unique shared facility that is completely open access, meaning our tech centre is open to anyone and everyone, regardless of affiliation or experience. Our goal is to provide easy access to multimillion-dollar microscopes that would otherwise be unavailable to a lot of researchers.

Research 104

Research Pharmaceuticals Disease Drugs 104

BioPharma Drive: Drug Pricing

JULY 5, 2023

Phase 2 results show a pill the company is developing is competitive with other oral medicines in testing against psoriasis, among them the TYK2 inhibitors that have drawn significant industry interest.

Drugs 113

Drugs 113

Drugs.com

JULY 5, 2023

WEDNESDAY, July 5, 2023 -- For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control. But some patients, particularly those beset by homelessness, drug.

Drugs 131

Drugs 131

Perficient: Drug Development

JULY 4, 2023

A small tip can be a lifesaver when it comes to customizing a platform or an existing system. It’s crucial to first grasp the implementation details and then follow the correct path to add new functionality or make changes to existing features. However, if you’re unfamiliar with a particular area of the system and are tasked with making a specific change, it can be time-consuming to identify where to start and exactly where to make the necessary modifications to meet the requirement.

Production 105

Production 105

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

KIF1A

JULY 29, 2023

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A in New York: The 2023 KAND Family & Scientific Engagement Conference We won’t be posting next Saturday, but not for a lack of science!

RNA 98

RNA Clinical Trials Disease Government 98

Drug Discovery World

JULY 21, 2023

Cancer Research Horizons has signed a collaboration agreement to license the entire Twist Biopharma Solutions Library of Libraries. Under the terms of the agreement, Cancer Research Horizons will license Twist’s ‘Library of Libraries’, an collection of synthesised antibody libraries designed based on naturally occurring sequences that harness innovative structural and developability features to cover a wide range of antibody drug targets, for a period of five years.

Research 246

Research Licensing Licensing Drugs 246

Drug Target Review

JULY 31, 2023

Dear Readers, I am thrilled to announce the launch of our new series, “Beyond the Lab,” which promises to deliver high-level insights commissioned exclusively by Drug Target Review magazine. Our inaugural report is a groundbreaking exploration of the remarkable advancements in cell and gene therapy that are revolutionising the field of drug discovery.

Therapies 98

Therapies Disease Clinical Development Hospitals 98

BioPharma Drive: Drug Pricing

JULY 10, 2023

Three reports from Iceland spurred the EMA to evaluate whether certain Novo Nordisk drugs, including Ozempic, might cause thoughts of self harm.

Regulations 117

Regulations Drugs 117

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drugs.com

JULY 6, 2023

THURSDAY, July 6, 2023 -- Curious about what the differences are between hepatitis A, B, C, D and E? If so, you’ve come to the right place. Here, experts break down hepatitis infection by type to reveal what it is, the most common symptoms, how.

124

124

Perficient: Drug Development

JULY 31, 2023

In a comedy special, Jerry Seinfeld once humorously said, “I saw a study that said speaking in front of a crowd is considered the number one fear of the average person. I found that amazing. Number two was death. Death was number two? This means to the average person if you have to be at a funeral, you would rather be in the casket than doing the eulogy.” The crowd roared with laughter.

Science 98

Science Production Research Marketing 98

Drug Patent Watch

JULY 28, 2023

Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are eleven patents protecting… The post New patent expiration for Astrazeneca drug SYMBICORT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Discovery World

JULY 5, 2023

Mark Garner, PhD., Global Cancer Segment Market Manager at Agilent Technologies, recently sat down with DDW Editor Reece Armstrong to tell us about the developments in the ‘golden age’ of cancer research. RA: Please can you tell us a bit more about your role at Agilent? MG: I am responsible for Agilent’s cancer segment. You could describe my role as being a convener across all our cancer research-related product lines, our Medical Affairs team, and the rest of the organisation.

Research 246

Research Immune Response Pharmaceutical Companies Treatment 246

ProRelix Research

JULY 26, 2023

Ensuring the safety and efficacy of new drugs, medical devices, and biological products does not end once the treatment is approved or is on the market but extends to the […] The post Pharmacovigilance (PV) Services at a Glance appeared first on ProRelix Research.

Production 98

Production Treatment Marketing Research 98

BioPharma Drive: Drug Pricing

JULY 17, 2023

For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.

RNA 98

RNA Drugs Disease 98

Drugs.com

JULY 6, 2023

THURSDAY, July 6, 2023 -- Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly reported cases of chronic hepatitis C? To help you.

Treatment 119

Treatment Disease 119

Antidote

JULY 27, 2023

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.

Clinical Research 98

Clinical Research Research Clinical Trials Packaging 98

Perficient: Drug Development

JULY 26, 2023

At Perficient, we are proud to work with incredible people who give their time and talent to support our clients and communities. Through our People Promise , we strive to challenge, champion, and celebrate the difference that our colleagues are making. For Louise Kraus, a business coordinator based in New Jersey, each day offers the chance to discover new concepts and continue growing as a leader.

International 98

International 98

Drug Discovery World

JULY 28, 2023

A report by University of Queensland (UQ) researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics. The Centre for Superbug Solutions at UQ’s Institute for Molecular Bioscience has monitored the clinical pipeline for more than a decade, with its latest snapshot showing 62 new antibiotics in development.

Pharmaceutical Companies 243

Pharmaceutical Companies Pharmaceuticals Doctors Vaccine 243

Science Daily: Pharmacology News

JULY 25, 2023

Important ocean currents that redistribute heat, cold and precipitation between the tropics and the northernmost parts of the Atlantic region will shut down around the year 2060 if current greenhouse gas emissions persist. This is the conclusion based on new calculations that contradict the latest report from the IPCC.

98

98

BioPharma Drive: Drug Pricing

JULY 31, 2023

According to the company, FDA officials have signaled openness to using a surrogate endpoint for assessing accelerated approval of a treatment for limb-girdle muscular dystrophy.

Disease 98

Disease FDA Treatment Drugs 98

Drugs.com

JULY 4, 2023

TUESDAY, July 4, 2023 -- Bacteria found in hospital patients in Ukraine is showing extreme antibiotic resistance, making it harder to treat the wounded and ill in this war-torn country, new research warns. “I am quite thick-skinned and have.

Hospitals 119

Hospitals Research 119

KIF1A

JULY 22, 2023

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A Plant Flavonol Rescues a Pathogenic Mutation Associated with Kinesin in Neurons We’ve spoken in the past about the power of worms: C. elegans models were used by Dr.

Small Molecule 98

Small Molecule FDA Disease Treatment 98

Broad Institute

JULY 20, 2023

A look back at the first year of NeuroDev By Makenzie Kohler July 20, 2023 Breadcrumb Home A look back at the first year of NeuroDev Researchers are working to characterize the genetic and phenotypic data of people with neurodevelopmental conditions in Kenya and South Africa. By Makenzie Kohler July 20, 2023 Credit: Aga Khan University Institute for Human Development NeuroDev researchers from Kenya, South Africa, and the United States at a meeting in Nairobi, Kenya.

Research 98

Research Doctors Disease 98

Drug Discovery World

JULY 5, 2023

The Summer 2023 issue of Drug Discovery World Magazine is out now and includes an exclusive guide on Therapeutic Antibodies. Featuring a  Therapeutic Spotlight on Immuno-oncology ,  the magazine is available to download free  here  and read for free on the DDW App. You can also request to receive a copy of the printed magazine  here. Key features of the Summer issue include a market report on India’s drug discovery sector, advancing treatments in Alzheimer’s, and whether big data can chart

Treatment 242

Treatment Disease Drugs Marketing 242

Science Daily: Pharmacology News

JULY 4, 2023

A detailed analysis of the dietary habits of elephants showed surprising variation from meal to meal, which could have important ramifications for wildlife protection and conservation strategies.

105

105

BioPharma Drive: Drug Pricing

JULY 28, 2023

The British pharma is deepening its investment in genetic medicine through a deal for a group of Pfizer’s gene therapy delivery tools, while the New York giant cuts back.

Therapies 98

Therapies 98

Drugs.com

JULY 5, 2023

WEDNESDAY, July 5, 2023 -- Heather Anderson, a star Australian rules football player who died last November, is the first female professional athlete to be diagnosed with chronic traumatic encephalopathy, or CTE. "She is the first female athlete.

119

119

Drug Channels

JULY 21, 2023

Today’s guest post comes from Brent Clifton, Vice President of Product Management at CoverMyMeds. Brent discusses the challenges that patients, caregivers, and providers face when seeking access to medications requiring prior authorization. He explains how an electronic prior authorization solution can reduce delays and help patients start their therapies sooner—especially when patients and brands can play an active role in the process.

Therapies 98

Therapies Production Drugs 98